Abstract
Tumor neoantigens are at the core of immunological tumor control and response to immunotherapy. In silico prediction of tumor neoantigens from next-generation sequencing (NGS) data is possible but requires the assembly of complex, multistep computational pipelines and extensive data preprocessing. Using public data from two cancer cell lines, here we show how TIminer, a framework to perform immunogenomics analyses, can be easily used to assemble and run customized pipelines to predict cancer neoantigens from multisample NGS data.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39(1):1–10. https://doi.org/10.1016/j.immuni.2013.07.012
Galluzzi L, Chan TA, Kroemer G et al (2018) The hallmarks of successful anticancer immunotherapy. Sci Transl Med 10(459):eaat7807. https://doi.org/10.1126/scitranslmed.aat7807
Fridman WH, Pages F, Sautes-Fridman C et al (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12(4):298–306. https://doi.org/10.1038/nrc3245
Havel JJ, Chowell D, Chan TA (2019) The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer 19(3):133–150. https://doi.org/10.1038/s41568-019-0116-x
Lee CH, Yelensky R, Jooss K et al (2018) Update on tumor neoantigens and their utility: why it is good to be different. Trends Immunol 39(7):536–548. https://doi.org/10.1016/j.it.2018.04.005
Schumacher TN, Scheper W, Kvistborg P (2018) Cancer neoantigens. Annu Rev Immunol. https://doi.org/10.1146/annurev-immunol-042617-053402
Gfeller D, Bassani-Sternberg M (2018) Predicting antigen presentation-what could we learn from a million peptides? Front Immunol 9:1716. https://doi.org/10.3389/fimmu.2018.01716
Tappeiner E, Finotello F, Charoentong P et al (2017) TIminer: NGS data mining pipeline for cancer immunology and immunotherapy. Bioinformatics 33(19):3140–3141. https://doi.org/10.1093/bioinformatics/btx377
Hackl H, Charoentong P, Finotello F et al (2016) Computational genomics tools for dissecting tumour-immune cell interactions. Nat Rev Genet 17(8):441–458. https://doi.org/10.1038/nrg.2016.67
McLaren W, Gil L, Hunt SE et al (2016) The ensembl variant effect predictor. Genome Biol 17(1):122. https://doi.org/10.1186/s13059-016-0974-4
Szolek A, Schubert B, Mohr C et al (2014) OptiType: precision HLA typing from next-generation sequencing data. Bioinformatics 30(23):3310–3316. https://doi.org/10.1093/bioinformatics/btu548
Nielsen M, Lundegaard C, Blicher T et al (2007) NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One 2(8):e796. https://doi.org/10.1371/journal.pone.0000796
Hoof I, Peters B, Sidney J et al (2009) NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61(1):1–13. https://doi.org/10.1007/s00251-008-0341-z
Nielsen M, Andreatta M (2016) NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets. Genome Med 8(1):33. https://doi.org/10.1186/s13073-016-0288-x
Bray NL, Pimentel H, Melsted P et al (2016) Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol 34(5):525–527. https://doi.org/10.1038/nbt.3519
Charoentong P, Finotello F, Angelova M et al (2017) Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18(1):248–262. https://doi.org/10.1016/j.celrep.2016.12.019
van der Meer D, Barthorpe S, Yang W et al (2019) Cell model passports-a hub for clinical, genetic and functional datasets of preclinical cancer models. Nucleic Acids Res 47(D1):D923–D929. https://doi.org/10.1093/nar/gky872
Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545–15550. https://doi.org/10.1073/pnas.0506580102
Boegel S, Lower M, Bukur T et al (2014) A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. Oncoimmunology 3(8):e954893. https://doi.org/10.4161/21624011.2014.954893
Liu Y, Mi Y, Mueller T et al (2019) Multi-omic measurements of heterogeneity in HeLa cells across laboratories. Nat Biotechnol 37(3):314–322. https://doi.org/10.1038/s41587-019-0037-y
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kirchmair, A., Finotello, F. (2020). In Silico Prediction of Tumor Neoantigens with TIminer. In: Boegel, S. (eds) Bioinformatics for Cancer Immunotherapy. Methods in Molecular Biology, vol 2120. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0327-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0327-7_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0326-0
Online ISBN: 978-1-0716-0327-7
eBook Packages: Springer Protocols